These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1933785)

  • 1. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
    Ha CS; Choe JG; Kong JS; Allen PK; Oh YK; Cox JD; Edmund E
    Cancer; 2000 Sep; 89(6):1371-9. PubMed ID: 11002233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
    Re A; Ferrari S; Frata P; Pizzocaro C; Crippa C; Tucci A; Facchetti F; Grazioli L; Magrini SM; Rossi G
    Ann Oncol; 2008 May; 19(5):951-7. PubMed ID: 18209012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
    Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
    Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
    Harris EW; Rakow JI; Weiner M; Agress H
    J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
    Janicek M; Kaplan W; Neuberg D; Canellos GP; Shulman LN; Shipp MA
    J Clin Oncol; 1997 Apr; 15(4):1631-7. PubMed ID: 9193363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
    Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
    J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
    Burns DE; Schiffman FJ
    Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
    King SC; Reiman RJ; Prosnitz LR
    J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H
    J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
    Karimjee S; Brada M; Husband J; McCready VR
    Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal BG; Marcus R; Brecher M; Ternberg J; Behm FG; Cantor A; Wharam M; Chauvenet A
    J Clin Oncol; 1991 Sep; 9(9):1591-8. PubMed ID: 1714950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallium scans in the evaluation of residual masses after chemotherapy for seminoma.
    Warren GP; Einhorn LH
    J Clin Oncol; 1995 Nov; 13(11):2784-8. PubMed ID: 7595739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.